Abstract
Background & Objective: Fungi are responsible for producing infections in humans. While all humans are susceptible to these disorders, immunocompromised people are the most at risk. Although it appears that we have many antifungal drugs in clinical use, unfortunately, most antifungal drugs currently in use have serious limitations or some drawbacks in pharmacokinetic aspects such as they do not possess an adequate solubility. As complement, fungi have developed a significant resistance against them because of their indiscriminate and even irrational use in some cases. Considering such situation, there is an urgent need to develop new and more effective antifungal drugs.
Discussion: For such reason, in recent years there has been an incredible increase in the number of studies looking for new compounds with antifungal effects; in particular new structures obtained from natural products. While a large number of compounds with antifungal activities (some of them with novel structures) have been reported, very few have managed to be used therapeutically. In this review article, we have identified and discussed the main reasons for the poor results that have been obtained so far in order to find new antifungal drugs. Also, new strategies which could be under way to improve the search for new antifungal agents for therapeutic use are discussed here, remarking their scope and limitations.
Keywords: Antimicrobial, natural products, antifungal, target-based screening, new drugs, new strategies.
Current Organic Chemistry
Title:The Long and Winding Road to Convert an Antimicrobial Compound into an Antimicrobial Drug: An Overview from a Medicinal Chemistry Point of View
Volume: 21 Issue: 18
Author(s): Ricardo D. Enriz*, Fernando D. Suvire, Sebastian A. Andujar, Maria A. Alvarez, Marcela Vettorazzi, Juan G. Dolab and Sebastian Rojas
Affiliation:
- Department of Pharmacy, Faculty of Chemistry, Biochemistry and Pharmacy, San Luis University, Chacabuco 917, 5700, San Luis,Argentina
Keywords: Antimicrobial, natural products, antifungal, target-based screening, new drugs, new strategies.
Abstract: Background & Objective: Fungi are responsible for producing infections in humans. While all humans are susceptible to these disorders, immunocompromised people are the most at risk. Although it appears that we have many antifungal drugs in clinical use, unfortunately, most antifungal drugs currently in use have serious limitations or some drawbacks in pharmacokinetic aspects such as they do not possess an adequate solubility. As complement, fungi have developed a significant resistance against them because of their indiscriminate and even irrational use in some cases. Considering such situation, there is an urgent need to develop new and more effective antifungal drugs.
Discussion: For such reason, in recent years there has been an incredible increase in the number of studies looking for new compounds with antifungal effects; in particular new structures obtained from natural products. While a large number of compounds with antifungal activities (some of them with novel structures) have been reported, very few have managed to be used therapeutically. In this review article, we have identified and discussed the main reasons for the poor results that have been obtained so far in order to find new antifungal drugs. Also, new strategies which could be under way to improve the search for new antifungal agents for therapeutic use are discussed here, remarking their scope and limitations.
Export Options
About this article
Cite this article as:
Enriz D. Ricardo*, Suvire D. Fernando, Andujar A. Sebastian, Alvarez A. Maria, Vettorazzi Marcela, Dolab G. Juan and Rojas Sebastian, The Long and Winding Road to Convert an Antimicrobial Compound into an Antimicrobial Drug: An Overview from a Medicinal Chemistry Point of View, Current Organic Chemistry 2017; 21 (18) . https://dx.doi.org/10.2174/1385272821666161222113628
DOI https://dx.doi.org/10.2174/1385272821666161222113628 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prevention and Treatment of Allergic Asthma in Pregnancy: From Conventional Drugs to New Therapeutical Approaches
Current Pharmaceutical Biotechnology Editorial (Thematic Issue: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part I))
Current Molecular Pharmacology Subject Index to Volume 2
Current Pharmacogenomics Hereditary Heterozygous C2 Deficiency: Variable Clinical and Serological Manifestations Among Three Sisters
Current Rheumatology Reviews 5-Lipoxygenase: Regulation and Pharmacology
Medicinal Chemistry Reviews - Online (Discontinued) Emerging Role of Mucins in Epithelial to Mesenchymal Transition
Current Cancer Drug Targets Two Different Functions of Doxycycline Which is Both An Antimicrobial Agent and An Immune Modulator
Anti-Infective Agents in Medicinal Chemistry The Use of Microarrays to Characterize Neuropsychiatric Disorders: Postmortem Studies of Substance Abuse and Schizophrenia
Current Molecular Medicine Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Coronaviruses Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
Current Pharmaceutical Biotechnology The Need to Consider Context in the Evaluation of Anti-infectious and Immunomodulatory Effects of Vitamin A and its Derivatives
Current Drug Targets Clozapine Induced Eosinophilia in a Case of Schizoaffective Disorder
Current Psychopharmacology Editorial: (Thematic Issue: Occupational Exposure: An Undermined Risk Factor of Lung Diseases in the Informal Sectors of Developing Economy)
Current Respiratory Medicine Reviews Structure and Function in COPD
Current Respiratory Medicine Reviews Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]
Current Pharmaceutical Design Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism Recent Advances in Fe-MOF Compositions for Biomedical Applications
Current Medicinal Chemistry The FKBP51-Glucocorticoid Receptor Balance in Stress-Related Mental Disorders
Current Molecular Pharmacology Editorial [Hot Topic:Toward Translational Research on VIP AND PACAP (Executive Editor: A. Arimura)]
Current Pharmaceutical Design Meet The Guest Editor
Combinatorial Chemistry & High Throughput Screening